Drugs / Glycerinated German Cockroach Allergenic Extract
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02710136 | Feb 2016 → Apr 2017 | asthma, insect Stings, hypersensitivity to | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00434421 | Feb 2007 → Aug 2009 | allergic disease, asthma | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00829985 | Jan → Dec 2009 | asthma, perennial allergic rhinitis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT03541187 | Jul 2018 → Jun 2022 | chronic asthma | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycerinated German Cockroach Allergenic Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00829985 ↗ |
| Known as | German cockroach allergenic extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03541187 ↗ |
| Modality | Protein / enzyme biologic | “Active ingredient: a non-standardized allergen derived from the extraction and purification of proteins from German cockroach (Blattella germanica).” NCT03541187 ↗ |
| Route | Other | “placed under the tongue (sublingually) to dissolve” NCT00829985 ↗ |